Delivery Order SPE2DB24D1034-SPE2DB24FWCM2
Award Date
9/11/24
Potential Completion Date
9/12/24
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,295,172 units of the GARDASIL 9 SYRINGE 0.5ML vaccine. The contract has a firm fixed price ceiling value of $6,139.24 and a period of performance through July 31, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded various indefinite delivery contracts (IDCs) by the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,242.38, is for the delivery of 4,568,116,064 units of the GARDASIL 9 vaccine syringe (0.5 mL). The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The delivery order has a ceiling value of $23,398.17 and a firm fixed price pricing type. The contract does not have a set-aside designation and is...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,927,167 units of the GARDASIL 9 vaccine syringe (0.5 mL), with a ceiling value of $17,718.03 and a period of performance through April 16, 2025. The contract is not set aside and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,629.01, is for the delivery of 4,568,051,548 units of the GARDASIL 9 SYRINGE 0.5ML vaccine. The contract has an ultimate completion date of April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,606.42, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a firm fixed price pricing type and an ultimate completion date of November 16, 2023. This delivery order is a component of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,123.92 firm-fixed-price contract is for the delivery of 4565430340 units of the GARDASIL 9 vaccine syringe (0.5 ML). The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, at a ceiling value of $6,399.38. The contract has a firm fixed price pricing type and a final completion date of September 27, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,804.08 delivery order is for the supply of 4,565,936,210 units of the GARDASIL 9 vaccine syringe, a critical medical supply. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $7,086.14. The contract type is Firm Fixed Price and the period of performance extends through July 26, 2024. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) between...